Your browser doesn't support javascript.
loading
Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells.
Williams, James; Hurling, Chloe; Munir, Sabrina; Harley, Peter; Machado, Carolina Barcellos; Cujba, Ana-Maria; Alvarez-Fallas, Mario; Danovi, Davide; Lieberam, Ivo; Sancho, Rocio; Beales, Philip; Watt, Fiona M.
Afiliação
  • Williams J; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Hurling C; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Munir S; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Harley P; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Machado CB; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Cujba AM; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Alvarez-Fallas M; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Danovi D; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Lieberam I; Bit.bio, Babraham Research Campus, Cambridge, United Kingdom.
  • Sancho R; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
  • Beales P; Centre for Developmental Neurobiology and MRC Centre for Neurodevelopmental Disorders, King's College London, London, United Kingdom.
  • Watt FM; Centre for Gene Therapy and Regenerative Medicine, King's College London, Guy's Hospital, London, United Kingdom.
Front Cell Dev Biol ; 11: 1163825, 2023.
Article em En | MEDLINE | ID: mdl-37333983
ABSTRACT
Bardet-Biedl syndrome (BBS) is a ciliopathy with pleiotropic effects on multiple tissues, including the kidney. Here we have compared renal differentiation of iPS cells from healthy and BBS donors. High content image analysis of WT1-expressing kidney progenitors showed that cell proliferation, differentiation and cell shape were similar in healthy, BBS1, BBS2, and BBS10 mutant lines. We then examined three patient lines with BBS10 mutations in a 3D kidney organoid system. The line with the most deleterious mutation, with low BBS10 expression, expressed kidney marker genes but failed to generate 3D organoids. The other two patient lines expressed near normal levels of BBS10 mRNA and generated multiple kidney lineages within organoids when examined at day 20 of organoid differentiation. However, on prolonged culture (day 27) the proximal tubule compartment degenerated. Introducing wild type BBS10 into the most severely affected patient line restored organoid formation, whereas CRISPR-mediated generation of a truncating BBS10 mutation in a healthy line resulted in failure to generate organoids. Our findings provide a basis for further mechanistic studies of the role of BBS10 in the kidney.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article